Cannabis and Cancer (Part 1)
About this module:
Cancer is rapidly becoming the number one cause of mortality in many countries. Increasingly people diagnosed with cancer are turning to medicinal cannabis to treat symptoms/signs as well as treat the pathophysiology. In Part 1 of a two part presentation, medicinal cannabis educator and research Professor Kylie O’Brien, discusses the pathogenesis of cancer and how the endocannabinoid system is involved.
This presentation assumes an understanding of the endocannabinoid system and how CBD and THC work. This presentation is pitched at the level of healthcare practitioners and those with a background in biomedical sciences.
At the end of this module, learners will be able to:
Describe common symptoms and signs associated with cancer and its orthodox treatment that might be able to be addressed using medicinal cannabis.
Describe the key hallmarks of cancer.
Drawing on knowledge of the role of the endocannabinoid system in homeostasis, discuss how dysfunction of the endocannabinoid system may be relevant to the various symptoms and signs associated with cancer.
Explain how endocannabinoid system dysfunction is involved in the pathogenesis of cancer.
Professor Kylie O'Brien, PhD
Kylie has been leading doctor education on medicinal cannabis in Australia since 2018. Her courses were the first to receive RACGP Category 1 CPD accreditation. She also set up the pathway via the National Institute of Integrative Medicine Ethics Committee for doctors to apply to become authorised prescribers of medicinal cannabis under the TGA’s Authorised Prescriber Scheme.